Cat. No.: X22-05-ZQ629

Prosaikogenin D

Synonym: 103629-72-7; Prosapogenin D; Prosaikogenin D; (2R,3R,4S,5R,6R)-2-[[(3S,4R,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-Hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl]oxy]-6-methyloxane-3,4,5-triol

  • CAS Number: 103629-72-7
  • Compound CID: 101596922
Product Size
20 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Prosaikogenin D has been shown to have significant cytotoxicity against cancer cells and has anti-cancer properties. Prosaikogenin D has been shown to inhibit prostate cancer cells in vitro by decreasing the expression of prostate-specific antigen and inhibiting cell proliferation. This product can be used for research in the fields of medicine and pharmacy.
Molecular Weight
618.84
Molecular Formula
C36H58O8
Form
Powder
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Applications
Prosaikogenin D can be used for research in the fields of medicine and pharmacy.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0